Anti-PD-1 immunotherapy for the treatment of metastatic urothelial carcinoma in a kidney transplant recipient: a case report
This case demonstrates the feasibility of safely achieving stable cancer control in a kidney transplant patient with mUC without encountering graft rejection by using single-agent anti-PD-1 treatment.
Authors
- Lin Ma (ORCID: https://orcid.org/0000-0002-5698-3478)
- Xinrong Fan (ORCID: https://orcid.org/0009-0001-9586-0518)
- Zhigang Ji (ORCID: https://orcid.org/0000-0001-6603-3778)
- Ziming Jiang (ORCID: https://orcid.org/0000-0003-4762-7516)
- Xiaoyuan Li (ORCID: https://orcid.org/0009-0000-8250-5181)
- Ziyi Dai (ORCID: https://orcid.org/0009-0006-4917-3393)
- Houfeng Huang
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
Publication Details
- Journal
- BMC Nephrology
- Published
- 2024-10-31
- DOI
- https://doi.org/10.1186/s12882-024-03825-2
- Citations
- 2
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.15
Funders
- Peking Union Medical College Hospital